US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Claritev Corporation

33.56

-1.9800-5.57%

Post-market: 33.560.00000.00%19:30 EDT

Volume:99.13K

Turnover:3.39M

Market Cap:569.41M

PE:-1.98

High:35.67

Open:35.24

Low:33.50

Close:35.54

52wk High:73.68

52wk Low:11.50

Shares:16.97M

Float Shares:5.64M

Volume Ratio:0.83

T/O Rate:1.76%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-16.9879

EPS(LYR):-17.3000

ROE:-646.34%

ROA:1.19%

PB:-1.93

PE(LYR):-1.94

Loading ...

Overview Company News Filings

Claritev price target raised to $45 from $40 at Citi

Analysts Offer Insights on Healthcare Companies: Claritev (CTEV) and Qiagen (QGEN)

Claritev Corp : Canaccord Genuity Raises Target Price to $43 from $37

THOMSON REUTERS

Claritev Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Calendar of U.S. Earnings Expected in the Week Ahead

Claritev Q2 EPS $(3.49) Beats $(4.21) Estimate, Sales $257.478M Beat $244.813M Estimate

Benzinga Earnings

Claritev Q2 2026 Net Loss Narrows to $59.2 Million; Revenue Rises 6.6% to $257.5 Million

Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 Million

Claritev Corp Q2 Adjusted Ebitda USD 155.8 Million VS. Ibes Estimate USD 147 Million

THOMSON REUTERS

Claritev Corp Q2 Operating Income USD 23.409 Million

THOMSON REUTERS

Press Release: Claritev Corporation Reports Second Quarter 2026 Results

Claritev Corp Expected to Post a Loss of $4.13 a Share - Earnings Preview

Claritev Management to Join Canaccord Genuity Growth Conference Fireside Chat

Multiplan Publishes August 2026 Investor Presentation

Multiplan Q2 Net Profit Rises 61.78% to BRL 427.48 Million; Revenue Climbs 53.44% to BRL 552.39 Million

Multiplan Fecha 2º Trimestre Com Lucro E Receita Acima Do Esperado

Claritev Report Flags Federal Eligibility Issues in Nearly 50% of 2025 no Surprises Act IDR Filings Reviewed

Claritev Sees no Surprises Act IDR Dispute Initiations Top 5.1 Million Through January 2026

Claritev Partners with SAVVI Financial on Benefits Decision Support Tool

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/CTEV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CTEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":33.56,"timestamp":1789588800000,"preClose":35.54,"halted":0,"volume":99128,"hourTrading":{"tag":"盘后","latestPrice":33.56,"preClose":33.56,"latestTime":"19:30 EDT","volume":8119,"amount":272473.64,"timestamp":1789601403406,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05571187394485078,"floatShares":5637600,"shares":16966900,"eps":-16.987898,"marketStatus":"Not Yet Opened","change":-1.98,"latestTime":"09-16 16:00:00 EDT","open":35.24,"high":35.67,"low":33.5,"amount":3387956.14152,"amplitude":0.061058,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-16.987898,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":35.54,"preHourTrading":{"tag":"盘前","latestPrice":36.3,"preClose":35.54,"latestTime":"09:17 EDT","volume":267,"amount":9490.270161,"timestamp":1789564652479,"change":0.76,"changeRate":0.021384,"amplitude":0.06753},"postHourTrading":{"tag":"盘后","latestPrice":33.56,"preClose":33.56,"latestTime":"19:30 EDT","volume":8119,"amount":272473.64,"timestamp":1789601403406,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.827464,"impliedVol":1.0474,"impliedVolPercentile":0.4263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","floatShares":5637600,"roa":"1.19%","roe":"-646.34%","lyrEps":-17.3,"volumeRatio":0.827464,"shares":16966900,"dividePrice":0,"high":35.67,"amplitude":0.061058,"preClose":35.54,"low":33.5,"week52Low":11.5,"pbRate":"-1.93","psRate":"0.57","week52High":73.68,"institutionHeld":0,"latestPrice":33.56,"eps":-16.987898,"divideRate":0,"volume":99128,"delay":0,"ttmEps":-16.987898,"open":35.24,"prevYearClose":42.75,"prevWeekClose":35.98,"prevMonthClose":39.83,"prevQuarterClose":34.11,"fiveDayClose":36.29,"twentyDayClose":35.6,"sixtyDayClose":28.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTEV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"CTEV","fiscalQuarterEnding":"2026/06","expectedEps":-4.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":-3.49},{"market":"US","date":"2026-05-07","symbol":"CTEV","fiscalQuarterEnding":"2026/03","expectedEps":-3.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-4.41},{"market":"US","date":"2026-02-23","symbol":"CTEV","fiscalQuarterEnding":"2025/12","expectedEps":-3.96,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"post","actualEps":-4.88},{"market":"US","date":"2025-11-07","symbol":"CTEV","fiscalQuarterEnding":"2025/09","expectedEps":-3.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-4.07},{"market":"US","date":"2025-08-06","symbol":"CTEV","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTEV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTEV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1780113600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTEV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTEV","date":"2026-09-15","current":-1.975524,"percent":0.07013,"low":-3.349365,"twenty":-1.799289,"median":-1.349613,"eighty":-0.552224,"high":-0.170756,"avg":-1.248627,"sd":0.663579,"marketCap":617565551},"quantilePoints":[{"date":"2025-03-07","current":-0.191916,"twenty":-0.197447,"median":-0.191916,"eighty":-0.189456,"marketCap":315861468},{"date":"2025-03-14","current":-0.199101,"twenty":-0.197211,"median":-0.192162,"eighty":-0.187507,"marketCap":327686025},{"date":"2025-03-21","current":-0.195853,"twenty":-0.199101,"median":-0.195853,"eighty":-0.189456,"marketCap":322340677},{"date":"2025-03-28","current":-0.216127,"twenty":-0.207643,"median":-0.197969,"eighty":-0.191424,"marketCap":355708607},{"date":"2025-04-04","current":-0.196739,"twenty":-0.206718,"median":-0.199101,"eighty":-0.19231,"marketCap":323798499},{"date":"2025-04-11","current":-0.193589,"twenty":-0.205793,"median":-0.197132,"eighty":-0.19231,"marketCap":318615132},{"date":"2025-04-17","current":-0.199986,"twenty":-0.20599,"median":-0.198855,"eighty":-0.193117,"marketCap":329143847},{"date":"2025-04-25","current":-0.222131,"twenty":-0.206856,"median":-0.199101,"eighty":-0.193195,"marketCap":365589401},{"date":"2025-05-02","current":-0.218489,"twenty":-0.216127,"median":-0.199986,"eighty":-0.193707,"marketCap":359596132},{"date":"2025-05-09","current":-0.29687,"twenty":-0.216324,"median":-0.201167,"eighty":-0.194022,"marketCap":349553357},{"date":"2025-05-16","current":-0.381783,"twenty":-0.220201,"median":-0.203381,"eighty":-0.19477,"marketCap":449534692},{"date":"2025-05-23","current":-0.40691,"twenty":-0.226382,"median":-0.204415,"eighty":-0.195577,"marketCap":479120156},{"date":"2025-05-30","current":-0.501692,"twenty":-0.309019,"median":-0.20658,"eighty":-0.196207,"marketCap":590723101},{"date":"2025-06-06","current":-0.536032,"twenty":-0.373826,"median":-0.209041,"eighty":-0.196739,"marketCap":631156569},{"date":"2025-06-13","current":-0.526958,"twenty":-0.383151,"median":-0.211797,"eighty":-0.196817,"marketCap":620472929},{"date":"2025-06-20","current":-0.563252,"twenty":-0.405877,"median":-0.216127,"eighty":-0.197014,"marketCap":663207489},{"date":"2025-06-27","current":-0.596754,"twenty":-0.523385,"median":-0.218587,"eighty":-0.197388,"marketCap":702654774},{"date":"2025-07-03","current":-0.634165,"twenty":-0.535753,"median":-0.22026,"eighty":-0.197624,"marketCap":746704243},{"date":"2025-07-11","current":-0.664735,"twenty":-0.548455,"median":-0.222131,"eighty":-0.198609,"marketCap":782699891},{"date":"2025-07-18","current":-0.622299,"twenty":-0.561577,"median":-0.261715,"eighty":-0.199101,"marketCap":732733330},{"date":"2025-07-25","current":-0.582376,"twenty":-0.582376,"median":-0.309814,"eighty":-0.199101,"marketCap":685725314},{"date":"2025-08-01","current":-0.556552,"twenty":-0.579166,"median":-0.371453,"eighty":-0.199593,"marketCap":655318032},{"date":"2025-08-08","current":-1.363933,"twenty":-0.582376,"median":-0.381783,"eighty":-0.199986,"marketCap":904797938},{"date":"2025-08-15","current":-1.684055,"twenty":-0.596754,"median":-0.383039,"eighty":-0.199986,"marketCap":1117158561},{"date":"2025-08-22","current":-1.705165,"twenty":-0.609038,"median":-0.401745,"eighty":-0.201167,"marketCap":1131162171},{"date":"2025-08-29","current":-1.770481,"twenty":-0.629977,"median":-0.507694,"eighty":-0.20166,"marketCap":1174490987},{"date":"2025-09-05","current":-1.68033,"twenty":-0.646839,"median":-0.521375,"eighty":-0.202762,"marketCap":1114687336},{"date":"2025-09-12","current":-1.530824,"twenty":-0.692989,"median":-0.533938,"eighty":-0.203588,"marketCap":1015508829},{"date":"2025-09-19","current":-1.375606,"twenty":-1.377791,"median":-0.536381,"eighty":-0.203963,"marketCap":912541110},{"date":"2025-09-26","current":-1.23802,"twenty":-1.366268,"median":-0.537986,"eighty":-0.204336,"marketCap":821270524},{"date":"2025-10-03","current":-1.152588,"twenty":-1.327376,"median":-0.544198,"eighty":-0.20536,"marketCap":764597092},{"date":"2025-10-10","current":-1.44862,"twenty":-1.376798,"median":-0.552224,"eighty":-0.206383,"marketCap":960977125},{"date":"2025-10-17","current":-1.403918,"twenty":-1.382559,"median":-0.554947,"eighty":-0.207131,"marketCap":931322422},{"date":"2025-10-24","current":-1.649535,"twenty":-1.412162,"median":-0.558366,"eighty":-0.208608,"marketCap":1094258540},{"date":"2025-10-31","current":-1.640594,"twenty":-1.453339,"median":-0.563531,"eighty":-0.2091,"marketCap":1088327600},{"date":"2025-11-07","current":-1.538771,"twenty":-1.530228,"median":-0.579166,"eighty":-0.210084,"marketCap":1020780776},{"date":"2025-11-14","current":-2.137789,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"marketCap":730433464},{"date":"2025-11-21","current":-2.187607,"twenty":-1.633144,"median":-0.596754,"eighty":-0.215261,"marketCap":747454878},{"date":"2025-11-28","current":-2.615165,"twenty":-1.640942,"median":-0.60834,"eighty":-0.216127,"marketCap":893541571},{"date":"2025-12-05","current":-1.787134,"twenty":-1.682416,"median":-0.609806,"eighty":-0.216422,"marketCap":610622545},{"date":"2025-12-12","current":-1.88435,"twenty":-1.687561,"median":-0.622299,"eighty":-0.217741,"marketCap":643839090},{"date":"2025-12-19","current":-1.988338,"twenty":-1.707649,"median":-0.634165,"eighty":-0.218607,"marketCap":679369224},{"date":"2025-12-26","current":-2.064756,"twenty":-1.732682,"median":-0.647217,"eighty":-0.219198,"marketCap":705479742},{"date":"2026-01-02","current":-2.067658,"twenty":-1.769935,"median":-0.66969,"eighty":-0.220083,"marketCap":706471281},{"date":"2026-01-09","current":-1.509511,"twenty":-1.763775,"median":-0.697121,"eighty":-0.220595,"marketCap":515765349},{"date":"2026-01-16","current":-1.45389,"twenty":-1.7451,"median":-1.219145,"eighty":-0.221029,"marketCap":496760858},{"date":"2026-01-23","current":-1.453407,"twenty":-1.733974,"median":-1.267698,"eighty":-0.222131,"marketCap":496595602},{"date":"2026-01-30","current":-1.302504,"twenty":-1.730745,"median":-1.277756,"eighty":-0.226264,"marketCap":445035592},{"date":"2026-02-06","current":-1.243013,"twenty":-1.721556,"median":-1.273802,"eighty":-0.226559,"marketCap":424709050},{"date":"2026-02-13","current":-0.966358,"twenty":-1.711374,"median":-1.266581,"eighty":-0.29687,"marketCap":330182367},{"date":"2026-02-20","current":-1.127418,"twenty":-1.706407,"median":-1.25317,"eighty":-0.305635,"marketCap":385212761},{"date":"2026-02-27","current":-0.825068,"twenty":-1.703973,"median":-1.240517,"eighty":-0.309416,"marketCap":234552084},{"date":"2026-03-06","current":-1.03119,"twenty":-1.699304,"median":-1.200271,"eighty":-0.346407,"marketCap":293148724},{"date":"2026-03-13","current":-0.932787,"twenty":-1.693898,"median":-1.145072,"eighty":-0.367715,"marketCap":265174622},{"date":"2026-03-20","current":-0.893193,"twenty":-1.685808,"median":-1.125483,"eighty":-0.371872,"marketCap":253918770},{"date":"2026-03-27","current":-0.928129,"twenty":-1.68187,"median":-1.089934,"eighty":-0.374385,"marketCap":263850404},{"date":"2026-04-02","current":-0.979951,"twenty":-1.680728,"median":-1.034393,"eighty":-0.379047,"marketCap":278582328},{"date":"2026-04-10","current":-1.041088,"twenty":-1.661853,"median":-1.024785,"eighty":-0.382034,"marketCap":295962687},{"date":"2026-04-17","current":-1.144149,"twenty":-1.646486,"median":-1.027988,"eighty":-0.382369,"marketCap":325261006},{"date":"2026-04-24","current":-1.181996,"twenty":-1.643002,"median":-1.041088,"eighty":-0.383151,"marketCap":336020276},{"date":"2026-05-01","current":-1.416649,"twenty":-1.641469,"median":-1.087406,"eighty":-0.393983,"marketCap":402727750},{"date":"2026-05-08","current":-1.436454,"twenty":-1.640942,"median":-1.117261,"eighty":-0.40141,"marketCap":411577020},{"date":"2026-05-15","current":-1.396438,"twenty":-1.641469,"median":-1.133463,"eighty":-0.404844,"marketCap":400111607},{"date":"2026-05-22","current":-1.401198,"twenty":-1.641023,"median":-1.127418,"eighty":-0.463779,"marketCap":401475430},{"date":"2026-05-29","current":-1.461292,"twenty":-1.640924,"median":-1.144149,"eighty":-0.506494,"marketCap":418693697},{"date":"2026-06-05","current":-1.640383,"twenty":-1.640924,"median":-1.167292,"eighty":-0.515428,"marketCap":470007542},{"date":"2026-06-12","current":-1.905748,"twenty":-1.641657,"median":-1.200271,"eighty":-0.520705,"marketCap":546040681},{"date":"2026-06-18","current":-1.770091,"twenty":-1.674171,"median":-1.236729,"eighty":-0.525172,"marketCap":507171722},{"date":"2026-06-26","current":-2.0658,"twenty":-1.686673,"median":-1.248091,"eighty":-0.528354,"marketCap":591899234},{"date":"2026-07-02","current":-1.927763,"twenty":-1.697502,"median":-1.259914,"eighty":-0.533938,"marketCap":552348363},{"date":"2026-07-10","current":-1.957512,"twenty":-1.711374,"median":-1.268816,"eighty":-0.535753,"marketCap":560872258},{"date":"2026-07-17","current":-1.830185,"twenty":-1.733974,"median":-1.276749,"eighty":-0.536032,"marketCap":524389989},{"date":"2026-07-24","current":-1.384538,"twenty":-1.747881,"median":-1.279495,"eighty":-0.53673,"marketCap":396702050},{"date":"2026-07-31","current":-1.402983,"twenty":-1.736755,"median":-1.28934,"eighty":-0.537065,"marketCap":401986864},{"date":"2026-08-07","current":-1.596949,"twenty":-1.731391,"median":-1.299807,"eighty":-0.537819,"marketCap":457562656},{"date":"2026-08-14","current":-2.527372,"twenty":-1.754145,"median":-1.304922,"eighty":-0.539215,"marketCap":715521887},{"date":"2026-08-21","current":-2.040096,"twenty":-1.770169,"median":-1.307495,"eighty":-0.539856,"marketCap":577569539},{"date":"2026-08-28","current":-2.321447,"twenty":-1.778428,"median":-1.313628,"eighty":-0.546752,"marketCap":657222615},{"date":"2026-09-04","current":-2.340004,"twenty":-1.789196,"median":-1.33854,"eighty":-0.548679,"marketCap":662476328},{"date":"2026-09-11","current":-2.199329,"twenty":-1.792396,"median":-1.346227,"eighty":-0.550828,"marketCap":622649790},{"date":"2026-09-15","current":-2.18137,"twenty":-1.799289,"median":-1.349613,"eighty":-0.552224,"marketCap":617565551}],"updateTime":1789621268413},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTEV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658980569","title":"Claritev price target raised to $45 from $40 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980569?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:40","pubTimestamp":1786358435,"startTime":"0","endTime":"0","summary":"Citi analyst Daniel Grosslight raised the firm’s price target on Claritev (CTEV) to $45 from $40 and keeps a Buy rating on the shares. Published fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-45-from-40-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-45-from-40-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893749","title":"Analysts Offer Insights on Healthcare Companies: Claritev (CTEV) and Qiagen (QGEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893749?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:10","pubTimestamp":1786349406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Claritev (CTEV) and Qiagen (QGEN) with bullish senti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-claritev-ctev-and-qiagen-qgen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-claritev-ctev-and-qiagen-qgen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","XBI","XLV","BK4121","HCSG","LU0128526141.USD","LU2125909247.SGD","LU2125909593.SGD","BK4167","BK4585","LU0029874061.USD","QGEN","LU2433249047.HKD","LABU","LU1923622614.USD","BK4581","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658768607","title":"Claritev Corp : Canaccord Genuity Raises Target Price to $43 from $37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658768607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658768607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 13:53","pubTimestamp":1786341192,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44708E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657459649","title":"Claritev Corp Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657459649","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657459649?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:31","pubTimestamp":1786109510,"startTime":"0","endTime":"0","summary":"Claritev Corp reports results for the quarter ended June 30 - Earnings SummaryClaritev CorpCTEV.Nreported a quarterly adjusted loss of $3.49 per share for the quarter ended June 30, higher than the sa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614462","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657614462?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:00","pubTimestamp":1786096800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ACM Research Inc. Class A                       2Q       .42       BMO. Algonquin Power & Utilities Corp.                2Q       .03   6:30 AM. Alpha Metallurgical Resources Inc.               2Q      (.43)  7:30 AM. Construction Partners Inc. Class A              3Q      1.01       BMO. Kimbell Royalty Partners LP                      2Q       .23   7:00 AM. Park Hotels & Resorts Inc.                        2Q       .25       AMC. Plains All American Pipeline L.P.                2Q       .38   7:30 AM. Plains GP Hldgs LP Class A                      2Q       .46   7:30 AM. Rapid Micro BioSyss Inc. Class A                2Q      (.24)      BMO. Spectrum Brands Hldgs Inc.                       3Q      1.46   6:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMBC","ELVA","BODI","BCSF","ACH","CECO","BBIO","DMAC","BWMN","BTDR","ACHR","AMTM","ASTS","CCAP","ACM","CAMT","CIB","ATMU","CBLL","EMA","ALC","AQN","BKD","AXSM","DCH","BZH","CODI","AMR","AIOT","CRC","AAON","CLMT","ARQ","DCBO","CNTY","ALMR","ANAB","APEI","CTEV","UA","DH","ELTX","ACVA","CEVA","B","CGC","ANIP","ACMR","DCGO","CNDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657619214","title":"Claritev Q2 EPS $(3.49) Beats $(4.21) Estimate, Sales $257.478M Beat $244.813M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657619214","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657619214?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:23","pubTimestamp":1786094607,"startTime":"0","endTime":"0","summary":"Claritev (NYSE:CTEV) reported quarterly losses of $(3.49) per share which beat the analyst consensus estimate of $(4.21) by 17.1 percent. This is a 8.4 percent increase over losses of $(3.81) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61030820/claritev-q2-eps-3-49-beats-4-21-estimate-sales-257-478m-beat-244-813m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616098","title":"Claritev Q2 2026 Net Loss Narrows to $59.2 Million; Revenue Rises 6.6% to $257.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616098","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616098?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:01","pubTimestamp":1786093290,"startTime":"0","endTime":"0","summary":"Claritev Q2 2026 net loss narrows to $59.2 million; revenue rises 6.6% to $257.5 millionClaritev posted Q2 2026 revenue of USD 257.5 million, up 6.6% from a year earlier.Net loss narrowed to USD 59.2 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDLbdFvrm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657712616","title":"Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657712616","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657712616?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:01","pubTimestamp":1786093260,"startTime":"0","endTime":"0","summary":"BRIEF-Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 MillionAug 07  - Claritev Corp Q2 operating income USD 23.409 million.Q2 pretax profit USD -76.649 millionQ2 net income USD -59.226 millionQ2 adjusted EBITDA USD 155.8 million vs. IBES estimate USD 147 millionoutlook FY revenue USD 1,000-1,020 million vs. IBES estimate USD 993.5 millionoutlook FY adjusted EBITDA USD 610-620 million vs. IBES estimate USD 608.5 millionoutlook FY capex USD 160-170 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nPLXDJGFBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616765","title":"Claritev Corp Q2 Adjusted Ebitda USD 155.8 Million VS. Ibes Estimate USD 147 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616765?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:00","pubTimestamp":1786093201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nPLXDJGFBH:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616754","title":"Claritev Corp Q2 Operating Income USD 23.409 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616754?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:00","pubTimestamp":1786093201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nPLXDJGFBH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616237","title":"Press Release: Claritev Corporation Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616237?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:00","pubTimestamp":1786093200,"startTime":"0","endTime":"0","summary":"--  Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025. --  Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025. to revenues of $241.6 million for Q2 2025.--  Net loss of $59.2 million for Q2 2026, compared to net loss of $62.6. --  Adjusted EBITDA of $155.8 million for Q2 2026, an increase of 1.1%,compared to Adjusted EBITDA of $154.0 million for Q2 2025.--  Net cash provided by operating activities of $92.7","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENFR","EMLP","AMLP","BK4144","TNGY","UMI","BK4585","EIPI","BK4588","TCAF","BK4590","TPZ","NOBL","CGCV","BK4581","USAI","EIPX","IXJ","VHT","ET","MDST","BK4550","MLPA","BK4561","BK4167","AMZA","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657854086","title":"Claritev Corp Expected to Post a Loss of $4.13 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657854086","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657854086?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:28","pubTimestamp":1785936485,"startTime":"0","endTime":"0","summary":"Claritev Corp <CTEV.N> expected to post a loss of $4.13 a share - Earnings PreviewClaritev CorpCTEV.N,CTEV.Kis expected to  show a rise in quarterly revenue when it reports  results on August 7 for th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N44221X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553495","title":"Claritev Management to Join Canaccord Genuity Growth Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553495?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:02","pubTimestamp":1785844923,"startTime":"0","endTime":"0","summary":"Claritev management to join Canaccord Genuity Growth Conference fireside chatClaritev will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston.Management is scheduled for a fireside chat on Aug. 11, 2026 at 10:00 a.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on August 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL6LMfBW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300307","title":"Multiplan Publishes August 2026 Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300307","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300307?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:18","pubTimestamp":1785791913,"startTime":"0","endTime":"0","summary":"Multiplan publishes August 2026 investor presentationMultiplan published its August 2026 investor presentation covering Brazil’s shopping center market, company positioning, 2Q26 operating-financial p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3wByXj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655138693","title":"Multiplan Q2 Net Profit Rises 61.78% to BRL 427.48 Million; Revenue Climbs 53.44% to BRL 552.39 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655138693","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655138693?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:33","pubTimestamp":1785443597,"startTime":"0","endTime":"0","summary":"Multiplan Q2 net profit rises 61.78% to BRL 427.48 million; revenue climbs 53.44% to BRL 552.39 millionMultiplan posted net income of R$ 427.43 million in Q2 2026, rising from R$ 264.39 million a year earlier.Net revenue climbed to R$ 846.84 million, up from R$ 694.06 million in Q2 2025.Operating profit increased to R$ 664.5 million from R$ 426.55 million, while net financial expense narrowed to R$ 124.99 million from R$ 134.82 million.In the first half, net income totaled R$ 743.6 million, up from R$ 498.48 million; net revenue rose to R$ 1.67 billion from R$ 1.22 billion.Multiplan completed the sale of a 10% stake in BH Shopping for R$ 285 million, cutting its holding to 90%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Multiplan Em","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL89LBK2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655386137","title":"Multiplan Fecha 2º Trimestre Com Lucro E Receita Acima Do Esperado","url":"https://stock-news.laohu8.com/highlight/detail?id=2655386137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655386137?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:22","pubTimestamp":1785442953,"startTime":"0","endTime":"0","summary":"Multiplan fecha 2 trimestre com lucro e receita acima do esperadoSO PAULO, July 30 (Reuters)-A operadora de shopping centers e empreendimentos imobiliários MultiplanMULT3.SAdivulgou nesta quinta-feira","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nS0N3YG04E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655702058","title":"Claritev Report Flags Federal Eligibility Issues in Nearly 50% of 2025 no Surprises Act IDR Filings Reviewed","url":"https://stock-news.laohu8.com/highlight/detail?id=2655702058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655702058?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:01","pubTimestamp":1785416497,"startTime":"0","endTime":"0","summary":"Claritev report flags federal eligibility issues in nearly 50% of 2025 No Surprises Act IDR filings reviewedClaritev’s NSA Trend Report flagged potential federal eligibility issues in nearly 50% of 2025 No Surprises Act IDR filings it reviewed.CMS data showed more than 2.5 million federal IDR disputes filed in 2025, up from 1.5 million in 2024.Total IDR awards topped USD 15 billion, more than tripling year over year, raising cost and administrative pressure across the system.Claritev led non-payer IDR administrators by volume; it managed about 270,000 federal IDR arbitrations at national scale.Clients’ offers were selected in 20% of applicable determinations, versus 12% industrywide, rising to 24% in Q4 versus 15%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL23Sg7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655817579","title":"Claritev Sees no Surprises Act IDR Dispute Initiations Top 5.1 Million Through January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655817579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655817579?lang=en_us&edition=fundamental","pubTime":"2026-07-30 06:01","pubTimestamp":1785362464,"startTime":"0","endTime":"0","summary":"Claritev sees No Surprises Act IDR dispute initiations top 5.1 million through January 2026Claritev’s 2026 No Surprises Act trend report flags IDR dispute volume far above expectations, raising payer ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL12kMXv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654000780","title":"Claritev Partners with SAVVI Financial on Benefits Decision Support Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2654000780","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654000780?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:03","pubTimestamp":1785243802,"startTime":"0","endTime":"0","summary":"Claritev partners with SAVVI Financial on benefits decision support toolClaritev entered a collaboration with SAVVI Financial to launch Claritev Benefit Decision Support for employer benefits enrollme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLD33Ld:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654504582","title":"Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654504582","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654504582?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:00","pubTimestamp":1785153600,"startTime":"0","endTime":"0","summary":"– Phase 2a study of CTEV in coronary artery bypass grafting (CABG) is expected to start this quarter – – Progression of CTEV into human study supported by positive preclinical results presented at mul","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/27/3333474/0/en/Humacyte-Announces-FDA-Acceptance-of-IND-for-First-In-Human-Clinical-Study-of-CTEV-for-Coronary-Artery-Bypass-Grafting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","AV","BK4167","BK4588","CTEV","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":96,"code":"91000000","status":"200"}]}}